Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.69 |
| ▸ | KDM5A | P29375 | 4/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.40 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 3/20 | 0.39 |
| ▸ | BCHE | P06276 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6820435 | 0.98 | PAOX (0.72) | PAOXKDM5AKDM4CALDH1A1APOBEC3A | |
| SCHEMBL164414 | 0.93 | PAOX (0.66) | PAOXKDM5AKDM4CALDH1A1APOBEC3A | |
| SCHEMBL18550462 | 0.84 | KDM5A (0.55) | PAOXKDM5AKDM4CPHF8 | |
| SCHEMBL1147352 | 0.83 | PAOX (0.50) | PAOXKDM5AKDM4CALDH1A1APOBEC3A | |
| SCHEMBL2178380 | 0.82 | PAOX (0.53) | PAOXALDH1A1APOBEC3AAPOBEC3GACHE | |
| SCHEMBL24372448 | 0.82 | PAOX (0.55) | PAOXKDM5AKDM4CALDH1A1PHF8 | |
| SCHEMBL18858465 | 0.82 | PAOX (0.55) | PAOXKDM5AKDM4CALDH1A1PHF8 | |
| SCHEMBL6668912 | 0.81 | PAOX (0.48) | PAOXKDM5AKDM4CALDH1A1APOBEC3A | |
| SCHEMBL5393582 | 0.81 | KDM5A (0.58) | KDM5AKDM4CALDH1A1PHF8LMNA | |
| SCHEMBL6252756 | 0.80 | PAOX (0.58) | PAOXKDM5AKDM4CALDH1A1APOBEC3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160303062-A1 | ANTIMICROBIAL COMPOSITIONS AND METHOD OF USE | NATIONAL SCIENCE FOUNDATION | 2016-10-20 | — | — | US | disclosed |
| US-9380784-B2 | Antimicrobial compositions and methods of use | NATIONAL SCIENCE FOUNDATION | 2016-07-05 | — | — | US | disclosed |
| US-20160139136-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | WATERS TECHNOLOGIES CORPORATION (US) | 2016-05-19 | — | — | US | disclosed |
| US-20110165261-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC (US) | 2011-07-07 | — | — | US | disclosed |
| WO-2004041781-A1 | PREPARATION OF 3-AMINOALKYL-SUBSTITUTED INDOLE DERIVATIVES FROM PHENYLHYDRAZINES AND AMINOKETONES | SUVEN LIFE SCIENCES LIMITED (IN) | 2004-05-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160303062-A1 | ANTIMICROBIAL COMPOSITIONS AND METHOD OF USE | MPO, CUTA, LPO | PAOX 3362/4885KDM5A 3904/4885KDM4C 4315/4885 |
| US-20160139136-A1 | RAPID FLUORESCENCE TAGGING OF GLYCANS AND OTHER BIOMOLECULES WITH ENHANCED MS SIGNALS | FUT5, FUT6, CSGALNACT1 | PAOX 3475/4885KDM5A 3734/4885KDM4C 4213/4885 |
| US-20110165261-A1 | ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE | MPO, CUTA, LPO | PAOX 3514/4885KDM5A 3927/4885KDM4C 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.